Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.

Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.

Ras activation has been correlated with malignant and metastatic cancer phenotypes and poor prognosis for cancer patients. In the preclinical setting, Ras activation by mutation or EGFR amplification results in increased clonogenic cell survival and decreased tumor growth delay following irradiation...

Detaylı Bibliyografya
Asıl Yazarlar:	Cengel, K, Mckenna, W
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2005

Benzer Materyaller

Molecular radiosensitization of pancreatic carcinoma cell lines in vivo and in vitro
Yazar:: Cengel, K, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The influence of Ras pathway signaling on tumor radiosensitivity.
Yazar:: Kim, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Modifying radiosensitivity in tumors: Targeting the Ras-PI-3 kinase pathway.
Yazar:: Muschel, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The clinical implications of gemcitabine radiosensitization.
Yazar:: Doyle, T, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
Yazar:: Kim, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Molecular Biomarkers for Predicting Cancer Patient Radiosensitivity and Radiotoxicity in Clinical Practice
Yazar:: Angeliki Gkikoudi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1
Yazar:: Isabel Freund, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.
Yazar:: Brunner, T, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic
Yazar:: Yuewen Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells.
Yazar:: Cengel, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting
Yazar:: Katharina Hintelmann, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Targeting active RAS with molecular glue
Yazar:: Wenjing Su, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia
Yazar:: Taeko Kaburagi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Targeting RAF dimers in RAS mutant tumors: From biology to clinic
Yazar:: Huanhuan Yin, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

PHOTOSENSITIZERS AS RADIOSENSITIZING AGENTS IN EXPERIMENTAL AND CLINICAL NEUROONCOLOGY
Yazar:: D. A. Tzerkovsky
Baskı/Yayın Bilgisi: (2017-09-01)

Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity.
Yazar:: Prevo, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
Yazar:: Lydia Koi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
Yazar:: Yanqing Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Targeting the organelle for radiosensitization in cancer radiotherapy
Yazar:: Xiaoyan Sun, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Yazar:: Md Entaz Bahar, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Increasing radiosensitivity by alleviating tumour hypoxia: a drug screen reveals atovaquone as a clinical candidate
Yazar:: Ashton, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The Role of Radiosensitizing Drugs in Osteosarcoma Treatment: Mechanisms and Clinical Perspectives
Yazar:: Zhang Y, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01)

Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
Yazar:: Radu O Minea, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Physiological Responses of Post-Dietary Effects: Lessons from Pre-Clinical and Clinical Studies
Yazar:: Christy Yeung, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Highlights on molecular targets for radiosensitization of breast cancer cells: Current research status and prospects
Yazar:: Zhi‐Rui Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
Yazar:: Sandra Cotino-Nájera, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Ras inhibitors and radiation therapy.
Yazar:: Jones, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers
Yazar:: Dongping Wei, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Lessons learned from pre-clinical testing of xenogeneic decellularized esophagi in a rabbit model
Yazar:: Edward Hannon, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Radiation sensitization by inhibition of activated Ras.
Yazar:: Brunner, T, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Radiosensitization: Studies and Modern Approaches to Cellular Radiosensitivity
Yazar:: Juan C. Alamilla-Presuel
Baskı/Yayın Bilgisi: (2023-09-01)

Targeting acid ceramidase to improve the radiosensitivity of rectal cancer
Yazar:: Clifford, R, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
Yazar:: Qiao, B, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Multi target analysis of HeLa cells radiosensitivity
Yazar:: Khairuddin, Ili Zawani
Baskı/Yayın Bilgisi: (2015)

Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer
Yazar:: Rachael E. Clifford, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Molecular inhibition of RAS signalling to target ageing and age-related health
Yazar:: Mihails Laskovs, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning
Yazar:: Sarah Rouhana, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Depletion of Signal Recognition Particle 72kDa increases radiosensitivity
Yazar:: Prevo, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
Yazar:: Al-Assar, O, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
Yazar:: Stephen M Schleicher, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)